Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2013 3
2014 3
2015 7
2016 16
2017 19
2018 14
2019 19
2020 24
2021 28
2022 21
2023 16
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 32385164

135 results

Results by year

Filters applied: . Clear all
Page 1
Interim PET Evaluation in Diffuse Large B-Cell Lymphoma Using Published Recommendations: Comparison of the Deauville 5-Point Scale and the ΔSUVmax Method.
Rekowski J, Hüttmann A, Schmitz C, Müller SP, Kurch L, Kotzerke J, Franzius C, Weckesser M, Bengel FM, Freesmeyer M, Hertel A, Krohn T, Holzinger J, Brink I, Haberkorn U, Nyuyki F, van Assema DME, Geworski L, Hasenclever D, Jöckel KH, Dührsen U. Rekowski J, et al. J Nucl Med. 2021 Jan;62(1):37-42. doi: 10.2967/jnumed.120.244145. Epub 2020 May 8. J Nucl Med. 2021. PMID: 32385164 Free article. Clinical Trial.
Interim FDG18-PET SUVmax Variation Adds Prognostic Value to Deauville 5-Point Scale in the Identification of Patients with Ultra-High-Risk Diffuse Large B Cell Lymphoma.
Duarte S, Roque A, Saraiva T, Afonso C, Marques BA, Lima CB, Neves D, Lai AC, Costa G, Cipriano A, Geraldes C, Ruzickova L, Carda JP, Gomes M. Duarte S, et al. Clin Lymphoma Myeloma Leuk. 2023 Feb;23(2):e107-e116. doi: 10.1016/j.clml.2022.11.009. Epub 2022 Nov 25. Clin Lymphoma Myeloma Leuk. 2023. PMID: 36567213 Free article.
Interim PET in Diffuse Large B-Cell Lymphoma.
Kurch L, Hüttmann A, Georgi TW, Rekowski J, Sabri O, Schmitz C, Kluge R, Dührsen U, Hasenclever D. Kurch L, et al. J Nucl Med. 2021 Aug 1;62(8):1068-1074. doi: 10.2967/jnumed.120.255034. Epub 2020 Nov 27. J Nucl Med. 2021. PMID: 33246974 Free article.
Optimisation of metabolic criteria in the prognostic assessment in patients with lymphoma. A multicentre study.
Del Puig Cózar-Santiago M, García-Garzón JR, Moragas-Freixa M, Soler-Peter M, Bassa Massanas P, Sánchez-Delgado M, Sanchez-Jurado R, Aguilar-Barrios JE, Sanz-Llorens R, Ferrer-Rebolleda J. Del Puig Cózar-Santiago M, et al. Rev Esp Med Nucl Imagen Mol. 2017 Sep-Oct;36(5):304-311. doi: 10.1016/j.remn.2017.03.003. Epub 2017 May 5. Rev Esp Med Nucl Imagen Mol. 2017. PMID: 28483373 English, Spanish.
Baseline and interim PET-based outcome prediction in peripheral T-cell lymphoma: A subgroup analysis of the PETAL trial.
Schmitz C, Rekowski J, Müller SP, Hertenstein B, Franzius C, Ganser A, Bengel FM, Kroschinsky F, Kotzerke J, La Rosée P, Freesmeyer M, Hoeffkes HG, Hertel A, Behringer D, Mesters R, Weckesser M, Mahlmann S, Haberkorn U, Martens U, Prange-Krex G, Brenner W, Giagounidis A, Moeller R, Runde V, Sandmann M, Hautzel H, Wilop S, Krohn T, Dürk H, Heike M, Alashkar F, Brinkmann M, Trenn G, Wacker D, Kreisel-Büstgens C, Bernhard H, Heil G, Larisch R, Kurch L, Jöckel KH, Hoelzer D, Klapper W, Boellaard R, Dührsen U, Hüttmann A. Schmitz C, et al. Hematol Oncol. 2020 Aug;38(3):244-256. doi: 10.1002/hon.2697. Epub 2020 Feb 18. Hematol Oncol. 2020. PMID: 32067259
135 results